Migraine Minute News Update

Rapid relief from a preventive migraine treatment? A study published in Neurology shows that one oral gepant medication may start working right away to prevent migraine attacks. Molly O'Brien fills you in, in this Migraine Minute News Update. Read more: https://bit.ly/3Wvb1fU

The FDA has approved a new drug for the acute treatment of migraine with or without aura in adults. Molly O'Brien has the details and when it becomes available in this Migraine Minute News update.    Learn More: https://axsometherapeuticsinc.gcs-web.com/news-releases/news-release-details/axsome-therapeutics-announces-fda-approval-symbravor-meloxicam

Researchers in Boston found that CGRP-blocking drugs commonly used for migraine may help with endometriosis pain and lesion size. Molly O'Brien has the details in this Migraine Minute news update recognizing Endometriosis Awareness Month.  Read More: https://bit.ly/4jp0cG2 AMD Comorbidities Library: https://bit.ly/3CIrLtd

Cluster Headache Awareness Day is March 21st. In this Migraine Minute News Update Molly O'Brien explains findings from a study that found cluster headache, fibromyalgia, and migraine are frequently comorbid conditions. Learn More:  https://bit.ly/42pSNQS

According to a study published in Neurology, when compared to placebo, this gepant led to significantly greater ability to function normally and a greater reduction in activity limitation when taken during the prodrome phase of an attack. Molly O'Brien has the details in this Migraine Minute News Update.  Read More: https://bit.ly/3BY2J9d

Kids age 8+ now have access to a non-drug migraine treatment option. In this Migraine Minute News Update, Molly O'Brien explains the FDA clearance of Theranica's Nerivio device for acute and preventive migraine treatment in kids.   Read more: https://bit.ly/4fRXRk5

Researchers have identified elevated levels of the gene MERTK, (which is linked to cluster headaches) and its ligand Gal-3, in the nerve tissues of rats and in blood samples of people with cluster headache. In this Migraine Minute News Update Molly O'Brien breaks down what it means for people living with Cluster. Read More: https://bit.ly/3ZXzTQ0

Contrary to previous research, a study published in Neurology finds among women, there is no link between migraine and the risk of developing Parkinson's disease. Molly O'Brien explains in this Migraine Minute News Update.   Want to know more about Migraine and Parkinson's disease? Check out this article in AMD's Comorbidities library: https://bit.ly/3XZSaJB  

A small study published in the New England Journal of Medicine finds a single IV infusion of a Monoclonal Antibody targeting PACAP reduced monthly migraine days better than placebo. In this Migraine Minute News Update Molly O'Brien explains. Read More:  https://bit.ly/3XXXNrR

The National Institute of Neurological Disorders and Stroke awards a $2.4 million grant to researchers at the University of Texas Health to examine the link between the circadian clock and severe headache disorders. Molly O'Brien has details in this Migraine Minute News Update. Read more: bit.ly/3BsNwfT

A study finds treatment with anti-CGRP mAbs does not significantly affect blood pressure or increase the occurrence of hypertension (compared to general population trends) in people 60+. In this Migraine Minute, Molly O'Brien explains the findings.  Read More: bit.ly/3zpcYSB 

A study found that anti-CGRP monoclonal antibodies not only reduced absenteeism & presenteeism in Spain, they were found to be cost-effective too. Read more:  http:// bit.ly/3S1KS5Y I mage courtesy: DOI 10.1186/s10194-024-01727-0

A new study looks at the efficacy and safety of two gepant medications. Molly O'Brien will share the study findings in this Migraine Minute News update.  Read the study:  bit.ly/4cwJQar Image courtesy: Sage Journals. Cephalalgia doi: 10.1177/03331024241235156  

Light sensitivity and poor sleep quality in people with migraine, could the two be related? In a study published in the Journal of Headache and Pain, researchers looked at the impact photophobia may have on sleep quality in people with migraine. Molly O'Brien breaks it down in this Migraine Minute News Update. Learn more:  bit.ly/4cIJMUD

Caffeine habit? A new study looks at the link between episodic migraine and regular caffeine intake. Molly O'Brien will fill you in, in this latest Migraine Minute News Update. Learn more about the study at bit.ly/4bzLyXu

The US FDA clears another wearable drug-free migraine treatment device. In this Migraine Minute News Update, Molly O'Brien will tell you all about a new TENS device available for people with episodic migraine. Read more:  https://bit.ly/4aEZFe9

Many people with chronic migraine worry that their monthly preventive medication won't work as well at the end of the month as it did at the beginning. New research shows that two injectable CGRP monoclonal antibodies do not wear off at the end of the month. Molly O'Brien has the details in this #MigraineMinute News Update.   Read more: bit.ly/3w95WQn

A study in the Lancet found one oral gepant to be safe and effective in people with episodic migraine who have failed two to four classes of preventive treatments. Molly O'Brien explains in this Migraine Minute News Update. Read the study here:  https://bit.ly/3w3ZM45  

A new study looks at real-word effectiveness of Anti-CGRP monoclonal antibodies & OnabotulinumtoxinA for chronic migraine. Molly O'Brien will share the study findings in this Migraine Minute News update. Read the study:  https://bit.ly/4d1mPx1 *The graphic used in this content is courtesy of Grazzi, L., Giossi, R., Montisano, D.A. et al. Real-world effectiveness of Anti-CGRP monoclonal antibodies...

 Researchers at the University of California Los Angeles found changes in blood flow in the retina might explain why some people have visual migraine symptoms. Molly O'Brien has the details in this Migraine Minute News update.  Learn more: https://bit.ly/3xou7uw , https://bit.ly/4aErYZN

AMD is thrilled to share what we've learned so far from our HEADS Registry! Molly O'Brien goes over the exclusive new data in this Migraine Minute News Update. The HEADS Registry serves as a crucial resource for researchers and clinicians. It's not too late to share your experience, by doing so, you can help pave the way for more effective therapies, enhanced and personalized patient care, and imp...

Obesity is often connected with an increase in migraine frequency, severity and disability. In this Migraine Minute News Update, Molly O'Brien gives details on what we're learning about one MAB drug and its effectiveness in people with migraine and comorbid obesity.   Read more here: https://bit.ly/3ONRu6m  

New results from the OVERCOME study, published in Neurology,  Found that just over 31 percent of people living with migraine often or very often feel stigmatized. Molly O'Brien will fill you in on the details in this Migraine Minute News Update. 

Nerivio becomes the first drug-free Migraine Treatment to Receive Commercial Insurance Coverage in the US. Molly O'Brien explains in this Migraine Minute News Update. Read more here: https://bit.ly/3T6lKvL

We know Migraine and ADHD are comorbid, but there is still a lot left to learn about how they are connected. @Molly O'Brien will fill you in on new research that explores ADHD symptoms in people with migraine.  Sources: https://bit.ly/3vNm6hT